Kerr et al. [11] also reported that IDH1/2 mutations were detected in chondrosarcoma, but not in chondroblastic osteosarcomas, suggesting that mutation analysis of IDH1/2 has yielded a promising biomarker for distinguishing chondrosarcoma from chondroblastic osteosarcoma. This evidence concerns the gene IDH1 and chondrosarcoma.